Stryker CEO Kevin Lobo Is Incoming Chair At AdvaMed
Executive Summary
AdvaMed's next board chair will be Stryker CEO Kevin Lobo, who will fill the leadership role beginning next March, when current chair Nadim Yared's two-year tenure is over. Lobo pledged to to work to improve diversity in industry.
You may also be interested in...
Diversity, More Advocacy Among Lobo’s Top Priorities As New AdvaMed Board Chair
Stryker CEO Kevin Lobo says while repeal of the medical device tax is his top issue, there are four main priorities he wants to work on over the next two years as industry advocate group AdvaMed’s board chair. They include better public engagement, increased advocacy work with the new Congress, advancing new technology – especially start-ups – and increasing diversity in the medtech industry.
Filling The Device Sector's Diversity Gap: MedTech Color Builds Support
MedTech Color is focused on enhancing diversity in the device and diagnostics space and increasing thought leadership opportunities for people of color in the industry. The organization held a launch event at this year's MedTech Conference in Philadelphia, where Medtech Insight caught up with founder Kwame Ulmer.
A Helping Hand: 'MedTech Color' Aims To Move Minorities From Shop Floor To Executive Suite
Industry veteran Kwame Ulmer has cobbled together a new group to help address perceived racial disparities at device firms. "MedTech Color" has already attracted attention from heavy-hitters Johnson & Johnson, Medtronic, 3M and Danaher, as well as industry advocacy group AdvaMed.